imatinib mesylate has been researched along with Hypertension in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; Liang, J; Lin, L; Wei, X; Xu, W | 1 |
| Chang, K; Choo, EH; Ihm, SH; Jang, SW; Kim, HY; Kim, OR; Park, CS; Seung, KB | 1 |
| Deininger, M; Moslehi, JJ | 1 |
| Abu-Gazala, M; Almogy, G; Appelbaum, L; Bala, M; Elazary, R; Khalaileh, A; Khatib, A; Neuman, T; Rivkind, AI; Schlager, A | 1 |
| Blank, SD; Butrynski, JE; Corless, CL; Dressel, DM; Ebrahim, KS; Heinrich, MC; Hornick, JL; Long, KB | 1 |
| Abouzahir, A; Amezyane, T; Badaoui, M; El Khattabi, A; Elomri, N; Elqatni, M; Fatihi, J; Ghafir, D; Hammi, S; Jira, M; Mekouar, F; Sekkach, Y; Smaali, J | 1 |
| Cohen, DP; Demetri, GD; George, S; Lechner, T; Li, S; Reichardt, P | 1 |
| Chen, HW; Feng, KF; He, LF; Hu, H; Hua, JS; Li, Q; Ma, LK; Wang, L; Yu, H; Zhou, JL | 1 |
| Baumann, M; Duisters, RF; Heymans, S; Janssen, SH; Peutz-Kootstra, CJ; Pinto, YM; Schellings, MW; Schroen, B; van Leeuwen, RE | 1 |
| Löwenberg, B; Pinto, YM; Schellings, MW | 1 |
2 review(s) available for imatinib mesylate and Hypertension
| Article | Year |
|---|---|
Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.
Topics: Aniline Compounds; Antineoplastic Agents; Cardiovascular System; Clinical Trials as Topic; Dasatinib; Fusion Proteins, bcr-abl; Humans; Hypertension; Imatinib Mesylate; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Targeted Therapy; Nitriles; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; Quinolines | 2015 |
Malignant appendiceal GIST: case report and review of the literature.
Topics: Abscess; Antineoplastic Agents; Appendiceal Neoplasms; Benzamides; Diabetes Mellitus, Type 2; Gastrointestinal Stromal Tumors; Humans; Hypertension; Imatinib Mesylate; Immunohistochemistry; Male; Middle Aged; Neoadjuvant Therapy; Piperazines; Pyrimidines; Tomography, X-Ray Computed | 2010 |
1 trial(s) available for imatinib mesylate and Hypertension
| Article | Year |
|---|---|
Hypertension as a potential biomarker of efficacy in patients with gastrointestinal stromal tumor treated with sunitinib.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Blood Pressure; Carcinoma, Renal Cell; Child; Disease-Free Survival; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Hypertension; Imatinib Mesylate; Indoles; Kidney Neoplasms; Male; Middle Aged; Piperazines; Proportional Hazards Models; Prospective Studies; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors; Young Adult | 2012 |
7 other study(ies) available for imatinib mesylate and Hypertension
| Article | Year |
|---|---|
Adverse reactions of sorafenib, sunitinib, and imatinib in treating digestive system tumors.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Stromal Tumors; Humans; Hypertension; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Sorafenib; Sunitinib | 2018 |
Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
Topics: Animals; Benzamides; Blotting, Western; Collagen Type I; Collagen Type III; Fibroblasts; Fibrosis; Gene Expression; Hypertension; Hypertrophy, Left Ventricular; Imatinib Mesylate; Male; Myocardium; Phosphorylation; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta1; Ventricular Remodeling | 2014 |
Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation.
Topics: Anoctamin-1; Antineoplastic Agents; Atrial Fibrillation; Benzamides; Chloride Channels; Depression; Gastrointestinal Stromal Tumors; Humans; Hypercholesterolemia; Hypertension; Imatinib Mesylate; Immunohistochemistry; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Piperazines; Pleural Neoplasms; Polymerase Chain Reaction; Proto-Oncogene Proteins c-kit; Pyrimidines | 2010 |
[Durable efficacity and remission after treatment with imatinib mesylate for FIP1L1-PDGFRA transcript negative associated eosinophilic cardiomyopathy].
Topics: Adult; Asthma; Benzamides; Electrocardiography; Eosinophils; Female; Humans; Hypereosinophilic Syndrome; Hypertension; Hypertension, Pulmonary; Imatinib Mesylate; Leukocyte Count; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Protease Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha | 2011 |
Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRα activity.
Topics: Animals; Benzamides; Blood Pressure; Blotting, Western; Desoxycorticosterone; Disease Models, Animal; Endomyocardial Fibrosis; Fibronectins; Fibrosis; Hypertension; Imatinib Mesylate; Male; Nephrectomy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Tenascin; Treatment Outcome | 2012 |
Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats.
Topics: Animals; Animals, Genetically Modified; Arterioles; Benzamides; Blood Pressure; Cells, Cultured; Fibrosis; Heart Diseases; Hemodynamics; Homozygote; Hypertension; Imatinib Mesylate; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Male; Myocardium; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor beta; Renin; Signal Transduction; Transcriptional Activation | 2006 |
Another look at imatinib mesylate.
Topics: Animals; Benzamides; Heart; Heart Failure; Humans; Hypertension; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats | 2007 |